Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points. (NCT06241404) | Clinical Trial Compass
CompletedNot Applicable
Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points.
Spain80 participantsStarted 2023-10-01
Plain-language summary
Background: Shoulder pain commonly affects the general population, with rotator cuff tendinopathy being the most common cause.
the most common cause, with rotator cuff tendinopathy diminishing function and quality of life, leading to a major socio-economic impact.
quality of life, leading to a major socio-economic impact. As a result, there are two treatment approaches with potential effectiveness: therapeutic exercise (TE) and myofascial trigger point treatment (TMT).
trigger point treatment (TTP).
Objective: The main objective of this randomised clinical trial is to determine the efficacy of ET versus treatment of MTPs in shoulder tendinopathies.
Methods: For this study, 20 participants were randomly divided into two groups: a ET group, with which a 10-exercise programme was initiated (n = 10), and a PGM group which was given an intervention protocol (n = 10).
intervention protocol (n = 10). Both received a total of 10 sessions. Pain intensity pain intensity, pressure pain threshold (PPT) and range of motion (ROM) were assessed before starting and after 10 sessions.
and after 10 sessions.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Signed informed consent form.
* Patients diagnosed by an orthopaedic surgeon with shoulder tendinopathy. tendinopathy.
* Symptoms of shoulder pain lasting more than 3 months.
* Pain on Jobe, Patte and infraspinatus assessment manoeuvres (highlighting abduction and abduction and external rotation).
Exclusion Criteria:
* Previous shoulder surgery.
* Radiating (non-referred) pain from cervical radiculopathy.
* Shoulder pain associated with other diagnoses (Examples: retractile capsulitis, subacromial syndrome, tendon rupture, posterosuperior conflict, etc.).
subacromial syndrome, tendon rupture, posterosuperior conflict, etc).
* Patients with multiple pathologies.
* Patients with neurological disorders.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Range of motion
Timeframe: At the end of Session 10 (each Session is 7 days)
2
pain intensity
Timeframe: At the end of Session 10 (each Session is 7 days)